Oregon Health and Science University Microarray Core Facility Licenses Metacore from Genego
News Nov 14, 2007
GeneGo, Inc. has announced that OHSU Affymetrix microarray core facility licensed a portfolio of its data analysis products. OHSU scientists will use MetaCore for pathway analysis; MetaDrug for chemogenomics, MapEditor for pathway editing and communication and MetaLink for adding their own interactions to MetaCore’s manually curated pathways.
The Affymetrix Microarray Core (AMC) facility provides RNA Expression Profiling and DNA Variation Analysis services using Affymetrix GeneChip® oligonucleotide arrays. DNA Variation services include genome wide SNP genotyping, copy number and LOH detection.
“We are very pleased to have the OHSU core microarray center as a GeneGo customer,” said Julie Bryant, Vice President of Business Development for GeneGo.
“OMICs core labs are our primary customers, as they provide both assays and analysis to the research communities at the universities. By having access to all of our tools OHSU will have a comprehensive platform for analyzing pathways, adding proprietary data through editing capabilities and easy sharing with colleagues by just right clicking on experiments or analyses.”
Massachusetts General Hospital (MGH) researchers have found that extracellular RNA (exRNA) in urine may be a source of biomarkers for the two most common forms of muscular dystrophy, noninvasively providing information about whether therapeutic drugs are having the desired effects on a molecular level.READ MORE
Is there a link between differences in IQ test performance and the activity of certain genes? Researchers have shown that modifications in the structure of a specific gene have a negative impact on individual test performance. This suggests that environmentally-induced epigenetic changes to our genetic material have a greater impact on intelligence than previously thought.